Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T22:51:55.103Z.
Calculation as of: 2026-10-06T22:51:55.103Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: de37dd0b2c1b76342df4d17673382af49ee3edc6a270b6d7b3ecb32e548b987f
PEG RATIO
N/A
Market Cap
$10.72B
PEG Ratio
0.45
TTM Avg
0.60
3Y Avg
2.18
5Y Avg
2.16
Market Cap
$12.37B
PEG Ratio
1.43
TTM Avg
2.71
3Y Avg
35.93
5Y Avg
61.65
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. (MDGL) | $11.47B | N/A | N/A | N/A | N/A |
| DaVita Inc. (DVA)vs › | $11.58B | 1.91 | 1.71 | 1.36 | 1.20 |
| Bio-Techne Corporation (TECH)vs › | $11.34B | 10.55 | 10.54 | 3.95 | 7.98 |
| The Cooper Companies, Inc. (COO)vs › | $11.01B | N/A | 0.23 | 0.61 | 1.18 |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.87B | N/A | N/A | N/A | N/A |
| Universal Health Services, Inc. (UHS)vs › | $10.72B | 0.45 | 0.60 | 2.18 | 2.16 |
| Encompass Health Corporation (EHC)vs › | $12.37B | 1.43 | 2.71 | 35.93 | 61.65 |
| ICON Public Limited Company (ICLR)vs › | $12.38B | N/A | 2.64 | 6.31 | 6.30 |
| Penumbra, Inc. (PEN)vs › | $12.49B | N/A | 4.12 | 4.12 | 4.12 |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.51B | 0.98 | 1.07 | 1.07 | 1.07 |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
